中国执业药师
中國執業藥師
중국집업약사
CHINA LICENSED PHARMACIST
2014年
12期
17-19,29
,共4页
肿瘤患者%免疫调节药物%点评模式
腫瘤患者%免疫調節藥物%點評模式
종류환자%면역조절약물%점평모식
Tumor Patient%Immunomodulatory Drug%Evaluation Mode
目的：建立科学化、标准化的肿瘤患者免疫调节药物处方点评模式，提高住院肿瘤患者免疫调节药物临床合理用药水平。方法：回顾性调查分析我院2012-2013年658份肿瘤患者住院医嘱，对其免疫调节药物的使用情况进行评价，归纳免疫调节药物评价指标和评价标准，建立免疫调节药物点评模式。结果：抽取的658份医嘱中，合格医嘱为495份，适应证及用法、用量适宜，合格率为75.2%；不合格医嘱为163份，多数为无适应证和超剂量使用，另有少部分为给药途径及稀释溶媒不适宜，不合格率为24.8%。结论：通过对住院肿瘤患者应用免疫调节药物的处方点评和分析，初步构建肿瘤辅助药物的评价体系。通过此体系的临床实践，使我院处方的不合格率明显降低。
目的：建立科學化、標準化的腫瘤患者免疫調節藥物處方點評模式，提高住院腫瘤患者免疫調節藥物臨床閤理用藥水平。方法：迴顧性調查分析我院2012-2013年658份腫瘤患者住院醫囑，對其免疫調節藥物的使用情況進行評價，歸納免疫調節藥物評價指標和評價標準，建立免疫調節藥物點評模式。結果：抽取的658份醫囑中，閤格醫囑為495份，適應證及用法、用量適宜，閤格率為75.2%；不閤格醫囑為163份，多數為無適應證和超劑量使用，另有少部分為給藥途徑及稀釋溶媒不適宜，不閤格率為24.8%。結論：通過對住院腫瘤患者應用免疫調節藥物的處方點評和分析，初步構建腫瘤輔助藥物的評價體繫。通過此體繫的臨床實踐，使我院處方的不閤格率明顯降低。
목적：건립과학화、표준화적종류환자면역조절약물처방점평모식，제고주원종류환자면역조절약물림상합리용약수평。방법：회고성조사분석아원2012-2013년658빈종류환자주원의촉，대기면역조절약물적사용정황진행평개，귀납면역조절약물평개지표화평개표준，건립면역조절약물점평모식。결과：추취적658빈의촉중，합격의촉위495빈，괄응증급용법、용량괄의，합격솔위75.2%；불합격의촉위163빈，다수위무괄응증화초제량사용，령유소부분위급약도경급희석용매불괄의，불합격솔위24.8%。결론：통과대주원종류환자응용면역조절약물적처방점평화분석，초보구건종류보조약물적평개체계。통과차체계적림상실천，사아원처방적불합격솔명현강저。
Objective:To set up a scientific and standardized prescription evaluation mode for tumor patients using immunomodulatory drugs, and to improve the level of clinical rational use of immunomodulatory drugs in tumor inpatients in hospital.Methods:A retrospective investigation and analysis were conducted of 658 pieces of medical orders of cancer patients in our hospital from 2012 to 2013,the application of immunomodulatory drugs was evaluated, the evaluation index and criteria were summed up,and an evaluation mode for the rational use of immunomodulatory drugs was established.Results:Among 658 medical orders 495 pieces(75.2%)were qualified with appropriate drug indications, usage and dosage, 163 pieces(24.8%)were unqualified and most of the prescriptions with no indications and overdose,or with inappropriate route of administration and dilution solvent. Conclusion:Through the prescription review and analysis of immunomodulatory drugs for hospitalized cancer patients,the evaluation system of tumor auxiliary drugs was preliminary established, and through practice with this system, unqualified prescription was significantly reduced.
